O-Desmethyl gefitinib
CAS No. 847949-49-9
O-Desmethyl gefitinib ( —— )
Catalog No. M22714 CAS No. 847949-49-9
O-Desmethyl gefitinib inhibits EGFR (IC50: 36 nM in subcellular assays). In human plasma, O-Desmethyl gefitinib is an active metabolite of Gefitinib.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 102 | In Stock |
|
10MG | 161 | In Stock |
|
25MG | 324 | In Stock |
|
50MG | 518 | In Stock |
|
100MG | 743 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameO-Desmethyl gefitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionO-Desmethyl gefitinib inhibits EGFR (IC50: 36 nM in subcellular assays). In human plasma, O-Desmethyl gefitinib is an active metabolite of Gefitinib.
-
DescriptionO-Desmethyl gefitinib inhibits EGFR (IC50: 36 nM in subcellular assays). In human plasma, O-Desmethyl gefitinib is an active metabolite of Gefitinib. The formation of O-desmethyl gefitinib is dependent on the CYP2D6 activity.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number847949-49-9
-
Formula Weight432.88
-
Molecular FormulaC21H22ClFN4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kobayashi H, et al. Effects of polymorphisms in CYP2D6 and ABC transporters and side effects induced by gefitinib on the pharmacokinetics of the gefitinib metabolite, O-desmethyl gefitinib. Med Oncol. 2016 Jun;33(6):57.
molnova catalog
related products
-
CHMFL-EGFR-202
CHMFL-EGFR-202 is a potent, irreversible inhibitor of EGFR mutant kinase (IC50s: 5.3 nM and 8.3 nM for drug-resistant mutant EGFR T790M and WT EGFR kinases).
-
AG18
AG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.
-
Cetuximab (anti-EGFR...
Cetuximab (anti-EGFR) is an inhibitor of epidermal growth factor receptor (EGFR).